Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gebhard Thoma

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|January 26, 1996
Synthesis of a Sialyl Lewis x Mimic with Fixed Carboxylic Acid Group: Chemical Approach toward the Elucidation of the Bioactive Conformation of Sialyl Lewis xGebhard Thoma, Franz Schwarzenbach, Rudolf O. Duthaler
Bioorganic & Medicinal Chemistry Letters|September 14, 2014
Selective inhibitors of the Janus kinase Jak3--Are they effective?Gebhard Thoma, Peter Drückes, Hans-Günter Zerwes
Expert Opinion on Drug Discovery|June 30, 2021
Drug discovery strategies for novel leukotriene A4 hydrolase inhibitorsTill A Röhn, Shin Numao, Heike Otto, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive ConformationGebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 5, 2003
Polymers bearing sLex-mimetics are superior inhibitors of E-selectin-dependent leukocyte rolling in vivoMajid Ali, Anne E R Hicks, Paul G Hellewell, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
Special ergolines efficiently inhibit the chemokine receptor CXCR3 in bloodGebhard Thoma, Rolf Baenteli, Ian Lewis, et al.
Journal of Medicinal Chemistry|December 16, 2010
Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase familyGebhard Thoma, Francois Nuninger, Rocco Falchetto, et al.
Journal of Medicinal Chemistry|December 5, 2008
Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivoGebhard Thoma, Markus B Streiff, Jiri Kovarik, et al.
Chemistry & Biology|March 29, 2011
Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptorsClaude Haan, Catherine Rolvering, Friedrich Raulf, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2008
Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivoGebhard Thoma, Christian Beerli, Marc Bigaud, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|January 26, 1996
Synthesis of a Sialyl Lewis x Mimic with Fixed Carboxylic Acid Group: Chemical Approach toward the Elucidation of the Bioactive Conformation of Sialyl Lewis xGebhard Thoma, Franz Schwarzenbach, Rudolf O. Duthaler
Bioorganic & Medicinal Chemistry Letters|September 14, 2014
Selective inhibitors of the Janus kinase Jak3--Are they effective?Gebhard Thoma, Peter Drückes, Hans-Günter Zerwes
Expert Opinion on Drug Discovery|June 30, 2021
Drug discovery strategies for novel leukotriene A4 hydrolase inhibitorsTill A Röhn, Shin Numao, Heike Otto, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Novel Concept for Super-Soft Topical Drugs: Deactivation by an Enzyme-Induced Switch into an Inactive ConformationGebhard Thoma, Eric Vangrevelinghe, Alexandre Luneau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 5, 2003
Polymers bearing sLex-mimetics are superior inhibitors of E-selectin-dependent leukocyte rolling in vivoMajid Ali, Anne E R Hicks, Paul G Hellewell, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2011
Special ergolines efficiently inhibit the chemokine receptor CXCR3 in bloodGebhard Thoma, Rolf Baenteli, Ian Lewis, et al.
Journal of Medicinal Chemistry|December 16, 2010
Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase familyGebhard Thoma, Francois Nuninger, Rocco Falchetto, et al.
Journal of Medicinal Chemistry|December 5, 2008
Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivoGebhard Thoma, Markus B Streiff, Jiri Kovarik, et al.
Chemistry & Biology|March 29, 2011
Jak1 has a dominant role over Jak3 in signal transduction through γc-containing cytokine receptorsClaude Haan, Catherine Rolvering, Friedrich Raulf, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2008
Reduced cardiac side-effect potential by introduction of polar groups: discovery of NIBR-1282, an orally bioavailable CCR5 antagonist which is active in vivoGebhard Thoma, Christian Beerli, Marc Bigaud, et al.
Pageof 3